Literature DB >> 23345058

Complexation of C60 fullerene with aromatic drugs.

Maxim P Evstigneev1, Anatoly S Buchelnikov, Dmitry P Voronin, Yuriy V Rubin, Leonid F Belous, Yuriy I Prylutskyy, Uwe Ritter.   

Abstract

The contributions of various physical factors to the energetics of complexation of aromatic drug molecules with C(60) fullerene are investigated in terms of the calculated magnitudes of equilibrium complexation constants and the components of the net Gibbs free energy. Models of complexation are developed taking into account the polydisperse nature of fullerene solutions in terms of the continuous or discrete (fractal) aggregation of C(60) molecules. Analysis of the energetics has shown that stabilization of the ligand-fullerene complexes in aqueous solution is mainly determined by intermolecular van der Waals interactions and, to lesser extent, by hydrophobic interactions. The results provide a physicochemical basis for a potentially new biotechnological application of fullerenes as modulators of biological activity of aromatic drugs.
Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23345058     DOI: 10.1002/cphc.201200938

Source DB:  PubMed          Journal:  Chemphyschem        ISSN: 1439-4235            Impact factor:   3.102


  6 in total

1.  C60 fullerene affects elastic properties and osmoregulation reactions of human lymphocytes.

Authors:  Marina Yu Skorkina; Evgenia A Sladkova; Elena A Shamray; Olga V Cherkashina; Maxim P Evstigneev; Anatoly S Buchelnikov; Yuriy I Prylutskyy; Uwe Ritter
Journal:  Eur Biophys J       Date:  2015-06-14       Impact factor: 1.733

2.  Interceptor effect of C60 fullerene on the in vitro action of aromatic drug molecules.

Authors:  Galyna B Skamrova; Ivan Laponogov; Anatoly S Buchelnikov; Yuriy G Shckorbatov; Svitlana V Prylutska; Uwe Ritter; Yuriy I Prylutskyy; Maxim P Evstigneev
Journal:  Eur Biophys J       Date:  2014-04-20       Impact factor: 1.733

3.  Complex of C60 Fullerene with Doxorubicin as a Promising Agent in Antitumor Therapy.

Authors:  Svitlana V Prylutska; Larysa M Skivka; Gennadiy V Didenko; Yuriy I Prylutskyy; Maxim P Evstigneev; Grygoriy P Potebnya; Rostyslav R Panchuk; Rostyslav S Stoika; Uwe Ritter; Peter Scharff
Journal:  Nanoscale Res Lett       Date:  2015-12-29       Impact factor: 4.703

4.  A nanocomplex of C60 fullerene with cisplatin: design, characterization and toxicity.

Authors:  Svitlana Prylutska; Svitlana Politenkova; Kateryna Afanasieva; Volodymyr Korolovych; Kateryna Bogutska; Andriy Sivolob; Larysa Skivka; Maxim Evstigneev; Viktor Kostjukov; Yuriy Prylutskyy; Uwe Ritter
Journal:  Beilstein J Nanotechnol       Date:  2017-07-20       Impact factor: 3.649

5.  C60 Fullerene as an Effective Nanoplatform of Alkaloid Berberine Delivery into Leukemic Cells.

Authors:  Anna Grebinyk; Svitlana Prylutska; Anatoliy Buchelnikov; Nina Tverdokhleb; Sergii Grebinyk; Maxim Evstigneev; Olga Matyshevska; Vsevolod Cherepanov; Yuriy Prylutskyy; Valeriy Yashchuk; Anton Naumovets; Uwe Ritter; Thomas Dandekar; Marcus Frohme
Journal:  Pharmaceutics       Date:  2019-11-08       Impact factor: 6.321

6.  Synergy of Chemo- and Photodynamic Therapies with C60 Fullerene-Doxorubicin Nanocomplex.

Authors:  Anna Grebinyk; Svitlana Prylutska; Oksana Chepurna; Sergii Grebinyk; Yuriy Prylutskyy; Uwe Ritter; Tymish Y Ohulchanskyy; Olga Matyshevska; Thomas Dandekar; Marcus Frohme
Journal:  Nanomaterials (Basel)       Date:  2019-10-30       Impact factor: 5.076

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.